$1M+ claims surged over the past five years
Costs up
104%
Prevalence up
110%
More members are hitting $1M in claims each year, and the treatments driving those costs are getting more expensive, driving higher employer risk and stop‑loss costs.
Stop-loss renewals jumped year
over year
3-5
point increase
With high‑cost claims rising, carriers and reinsurers priced more aggressively. Renewal increases for 2026 were 3–5 points higher than the prior year, adding pressure for employers already managing high‑cost claimant volatility.
Location of care choices drives catastrophic risk
3x-7x
price variation
Infusion pricing isn’t “regional noise.” The same infusion, in the same market, can cost 3x-7x more depending on site of care, making location of care one of the most powerful levers to control volatility.
1
2
3